A Phase I, Open-label, Single-center, Sequential Design Study in Healthy Volunteers to Determine the Relative Bioavailability of Different Oral Formulations of AZD9291 and the Effect of Food
To determine the relative bioavailability of different oral formulations of AZD9291 and the effect of food in healthy volunteers.